Helene Therapeutics Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 15462784

		31 December 2025		28 February 2025
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		1,644,587		737,372

			1,644,587		737,372
CURRENT ASSETS
Debtors	5	605,601		603,654
Cash at bank and in hand		281,190		1,777,581

		886,791		2,381,235
Creditors: Amounts Falling Due Within One Year	6	(621,858 )		(601,650 )

NET CURRENT ASSETS (LIABILITIES)			264,933		1,779,585

TOTAL ASSETS LESS CURRENT LIABILITIES			1,909,520		2,516,957

Creditors: Amounts Falling Due After More Than One Year	7		(1,745,329 )		(940,637 )

NET ASSETS			164,191		1,576,320

CAPITAL AND RESERVES
Called up share capital	8		2,500		12,500
Share premium account			2,497,500		2,497,500
Profit and Loss Account			(2,335,809 )		(933,680 )

SHAREHOLDERS' FUNDS			164,191		1,576,320

Page 1

Page 2

Helene Therapeutics Limited

Balance Sheet (continued)

As At 31 December 2025

For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Takaaki Matsuoka

Director

3 July 2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

Helene Therapeutics Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15462784 . The registered office is 15 Lavey House, 10 Belgrave Road, London, HA0 1AG.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Leasehold	10% Straight Line
Plant & Machinery	20% Reducing Balance
Fixtures & Fittings	20% Reducing Balance

2.3. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.

3. Average Number of Employees

Average number of employees, including directors, during the period was: 6 (2025: 4)

4. Tangible Assets

	Land & Property
	Leasehold	Plant & Machinery	Fixtures & Fittings	Total
	£	£	£	£
Cost
As at 1 March 2025	662,011	181,598	-	843,609
Additions	642,003	379,522	151,347	1,172,872

As at 31 December 2025	1,304,014	561,120	151,347	2,016,481

Depreciation
As at 1 March 2025	70,055	36,182	-	106,237
Provided during the period	130,401	104,987	30,269	265,657

As at 31 December 2025	200,456	141,169	30,269	371,894

Net Book Value
As at 31 December 2025	1,103,558	419,951	121,078	1,644,587

As at 1 March 2025	591,956	145,416	-	737,372

Page 3

Page 4

Helene Therapeutics Limited

Notes to the Financial Statements (continued)

For the Period 1 March 2025 to 31 December 2025

5. Debtors

	31 December 2025	28 February 2025
	£	£
Due within one year
Other debtors	200,601	198,654
Due after more than one year
Other debtors	405,000	405,000

	605,601	603,654

6. Creditors: Amounts Falling Due Within One Year

	31 December 2025	28 February 2025
	£	£
Trade creditors	236,480	182,264
Other creditors	376,877	414,542
Taxation and social security	8,501	4,844

	621,858	601,650

7. Creditors: Amounts Falling Due After More Than One Year

	31 December 2025	28 February 2025
	£	£
Other creditors	1,745,329	940,637

8. Share Capital

	31 December 2025	28 February 2025
	£	£
Allotted, Called up and fully paid	2,500	12,500